PCM vs. HQL, TYG, KTF, SOR, MCI, PPT, MIY, MHN, PMO, and ASG
Should you be buying PCM Fund stock or one of its competitors? The main competitors of PCM Fund include Abrdn Life Sciences Investors (HQL), Tortoise Energy Infrastructure (TYG), DWS Municipal Income Trust (KTF), Source Capital (SOR), Barings Corporate Investors (MCI), Putnam Premier Income Trust (PPT), BlackRock MuniYield Michigan Quality Fund (MIY), BlackRock MuniHoldings New York Quality Fund (MHN), Putnam Municipal Opportunities Trust (PMO), and Liberty All-Star Growth Fund (ASG). These companies are all part of the "investment offices, not elsewhere classified" industry.
PCM Fund (NYSE:PCM) and Abrdn Life Sciences Investors (NYSE:HQL) are both small-cap finance companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, institutional ownership, valuation, community ranking, dividends, profitability and media sentiment.
PCM Fund has a beta of 0.83, meaning that its stock price is 17% less volatile than the S&P 500. Comparatively, Abrdn Life Sciences Investors has a beta of 0.74, meaning that its stock price is 26% less volatile than the S&P 500.
PCM Fund received 92 more outperform votes than Abrdn Life Sciences Investors when rated by MarketBeat users. Likewise, 71.10% of users gave PCM Fund an outperform vote while only 68.35% of users gave Abrdn Life Sciences Investors an outperform vote.
PCM Fund pays an annual dividend of $0.96 per share and has a dividend yield of 12.2%. Abrdn Life Sciences Investors pays an annual dividend of $1.49 per share and has a dividend yield of 10.8%.
10.3% of PCM Fund shares are owned by institutional investors. Comparatively, 32.2% of Abrdn Life Sciences Investors shares are owned by institutional investors. 1.0% of PCM Fund shares are owned by company insiders. Comparatively, 10.1% of Abrdn Life Sciences Investors shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
In the previous week, Abrdn Life Sciences Investors had 1 more articles in the media than PCM Fund. MarketBeat recorded 3 mentions for Abrdn Life Sciences Investors and 2 mentions for PCM Fund. Abrdn Life Sciences Investors' average media sentiment score of 1.45 beat PCM Fund's score of 0.50 indicating that Abrdn Life Sciences Investors is being referred to more favorably in the news media.
Summary
PCM Fund and Abrdn Life Sciences Investors tied by winning 4 of the 8 factors compared between the two stocks.
Get PCM Fund News Delivered to You Automatically
Sign up to receive the latest news and ratings for PCM and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PCM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
PCM Fund Competitors List
Related Companies and Tools
